Last updated: May 1, 2026
What is METRO I.V. and which supplier inputs matter for sourcing?
“METRO I.V.” is a trade name used for intravenous (I.V.) formulations of metronidazole packaged in a plastic container (commonly I.V. bags). Supplier sourcing for this product typically falls into four input streams:
- Contract manufacturing (sterile liquid / IV infusion production)
- Plastic container and closure system (bag, ports, seals, overwrap, labels)
- Drug substance supply (metronidazole API) and sterile bulk drug product formulation components
- Distribution and sterile logistics (cold chain if required, GDP-compliant transport and warehousing)
Who are the suppliers?
Insufficient information is available in the provided prompt to identify the specific supplier set for “METRO I.V. IN PLASTIC CONTAINER” with the level of specificity required for a procurement or patent-analysis-grade answer (for example: label holder, MAH, site-level manufacturers, container/closure vendors, or country-specific branded product registrant names).
Under the constraint that a complete and accurate response cannot be produced, no supplier list can be returned.
Key Takeaways
- Supplier sourcing for “METRO I.V. in plastic container” depends on four input streams: sterile I.V. manufacturing, container-closure components, API and excipients, and GDP logistics.
- The prompt does not provide the regulatory-holder name, country/market, strength, volume, or packaging format required to map the branded product to its actual manufacturer and container suppliers.
- A precise supplier list cannot be produced without product/market-identifying details.
FAQs
1) Which supplier categories determine who “the suppliers” are for METRO I.V. in plastic containers?
Contract sterile manufacturing, container-closure systems, metronidazole API and formulation components, and GDP distribution.
2) Does “plastic container” mean all suppliers use the same bag supplier?
No. Bag and closure systems vary by market and approved packaging configuration.
3) Can API suppliers be treated as “suppliers for the finished drug”?
API suppliers supply drug substance upstream, but they are not the same as the contract manufacturer or the container-closure vendor.
4) Do container suppliers change when the product moves markets?
They can. Approved packaging must match the specific registered configuration in each regulatory jurisdiction.
5) Why can’t a supplier list be given from the trade name alone?
Because multiple branded versions exist across jurisdictions, strengths, and package types, each mapped to different manufacturing and packaging supply chains.
